Tomorrow! July 28, 5:30pm, Clinical Peer to Peer Discussion on Lung Cancer

 

This Weekly’s Hot Topics

  • Tomorrow! July 28, 5:30pm, Clinical Peer to Peer Discussion on Lung Cancer MOASC News/MOASC Programs
  • Tomorrow! July 28, 7:00pm, a virtual Roundtable on B-Cell Lymphoma: Third-Line Therapy for Relapsed/Refractory DLBCL MOASC News/MOASC Programs
  • Tomorrow! July 28, 2:30 pm, the next “Save MICRA” virtual Community Ambassador training California  News
  • July 29-31, Physicians Education Resource’s 22nd Annual International Lung Cancer Congress MOASC News/MOASC Programs
  • July 31 is the deadline to help independent physicians succeed in value-based care! California  News

Tomorrow! July 28, Clinical Peer to Peer Discussion on Lung Cancer, 5:30pm – 7:00pm. MOASC Secretary, Joshua Mansour, M.D., City of Hope will host moderator Hatim Husain, M.D., UCSD in a panel discussion of case presentations and discussion of various treatment options with; Munveer Bhangoo, M.D., Scripps MD Anderson Cancer Center; Jonathan Goldman, M.D., UCLA Hematology & Oncology. To read more click here and go to MOASC News/ MOASC Programs.

Proponents of the so-called “Fairness for Injured Patients Act” (FIPA) have continued to advocate for their trial attorney backed measure that will only limit access to care during the worst possible time by eliminating key MICRA protections for physicians. Thank you for your continued commitment to CAPP, and all you have done and continue to do for the health and wellbeing of millions of Californians. If you have not done so already, please take a moment to complete the sign-up form, below, to join the campaign coalition to oppose FIPA. As a reminder, even if you are a member of CAPP you must sign up on the link to formally oppose the initiative. To read more click here and go to California News.

Symptom burden stayed at pre-chemotherapy levels in cancer patients who received remote 24-hour monitoring and rose starting with the first chemotherapy cycle in patients who did not receive remote monitoring, according to a study in The BMJ. Patients in the intervention group used their mobile device to answer a questionnaire daily and whenever they felt unwell, symptoms were evaluated by the remote system, patients were directed to self-care resources, and clinicians received amber alerts for persistent mild to moderate symptoms and red alerts for emergencies. To read more click here and go to National News.

To read the complete edition of the California Oncology Weekly Newsletter, click on the date below.

July 28, 2021



No comments have been posted yet.